258 related articles for article (PubMed ID: 38499648)
1. Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications.
Safri F; Nguyen R; Zerehpooshnesfchi S; George J; Qiao L
Cancer Gene Ther; 2024 Mar; ():. PubMed ID: 38499648
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies.
Zhang Q; Lou Y; Bai XL; Liang TB
World J Gastroenterol; 2020 Jul; 26(26):3720-3736. PubMed ID: 32774053
[TBL] [Abstract][Full Text] [Related]
3. Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma.
Xu FQ; Dong MM; Wang ZF; Cao LD
Front Immunol; 2023; 14():1083069. PubMed ID: 36776894
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic options in hepatocellular carcinoma: a comprehensive review.
Suresh D; Srinivas AN; Prashant A; Harikumar KB; Kumar DP
Clin Exp Med; 2023 Oct; 23(6):1901-1916. PubMed ID: 36780119
[TBL] [Abstract][Full Text] [Related]
5. Bibliometric study of immunotherapy for hepatocellular carcinoma.
Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
[TBL] [Abstract][Full Text] [Related]
6. Cellular heterogeneity and plasticity in liver cancer.
Chan LK; Tsui YM; Ho DW; Ng IO
Semin Cancer Biol; 2022 Jul; 82():134-149. PubMed ID: 33647386
[TBL] [Abstract][Full Text] [Related]
7. Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma.
Huang A; Zhao X; Yang XR; Li FQ; Zhou XL; Wu K; Zhang X; Sun QM; Cao Y; Zhu HM; Wang XD; Yang HM; Wang J; Tang ZY; Hou Y; Fan J; Zhou J
J Hepatol; 2017 Aug; 67(2):293-301. PubMed ID: 28323123
[TBL] [Abstract][Full Text] [Related]
8. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.
Ahn JC; Teng PC; Chen PJ; Posadas E; Tseng HR; Lu SC; Yang JD
Hepatology; 2021 Jan; 73(1):422-436. PubMed ID: 32017145
[TBL] [Abstract][Full Text] [Related]
9. The Endless Sources of Hepatocellular Carcinoma Heterogeneity.
Barcena-Varela M; Lujambio A
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073538
[TBL] [Abstract][Full Text] [Related]
10. Implications of genetic heterogeneity in hepatocellular cancer.
Suresh A; Dhanasekaran R
Adv Cancer Res; 2022; 156():103-135. PubMed ID: 35961697
[TBL] [Abstract][Full Text] [Related]
11. Personalized treatment for hepatocellular carcinoma: Current status and future perspectives.
Chan SL; Wong N; Lam WKJ; Kuang M
J Gastroenterol Hepatol; 2022 Jul; 37(7):1197-1206. PubMed ID: 35570200
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for hepatocellular carcinoma: Current status and future perspectives.
Mandlik DS; Mandlik SK; Choudhary HB
World J Gastroenterol; 2023 Feb; 29(6):1054-1075. PubMed ID: 36844141
[TBL] [Abstract][Full Text] [Related]
13. Limited bias effect of intratumoral heterogeneity on genetic profiling of hepatocellular carcinoma.
Huang A; Wang YP; Wang J; Fu PY; Zhang X; Cao Y; Fan J; Yang XR; Zhou J
J Gastrointest Oncol; 2020 Feb; 11(1):112-120. PubMed ID: 32175113
[TBL] [Abstract][Full Text] [Related]
14. The multiple origin of cancer stem cells in hepatocellular carcinoma.
Anfuso B; El-Khobar KE; Sukowati CH; Tiribelli C
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S92-7. PubMed ID: 26186879
[TBL] [Abstract][Full Text] [Related]
15. A microRNA biomarker of hepatocellular carcinoma recurrence following liver transplantation accounting for within-patient heterogeneity.
Xie QY; Almudevar A; Whitney-Miller CL; Barry CT; McCall MN
BMC Med Genomics; 2016 Apr; 9():18. PubMed ID: 27059462
[TBL] [Abstract][Full Text] [Related]
16. Dissecting intratumor heterogeneity in HCC: new research strategies and clinical implications.
Behrens S; Wang XW
Carcinogenesis; 2022 Dec; 43(12):1103-1109. PubMed ID: 36512331
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities.
Kalasekar SM; VanSant-Webb CH; Evason KJ
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771685
[TBL] [Abstract][Full Text] [Related]
19. TGF-β and Hepatocellular Carcinoma: When A Friend Becomes An Enemy.
Arrese M; Hernandez A; Astete L; Estrada L; Cabello-Verrugio C; Cabrera D
Curr Protein Pept Sci; 2018; 19(12):1172-1179. PubMed ID: 29150921
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
